Drug Trial Radar · NCT00252863
DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
Last checked: Nov 20, 2026Latest source record: Mar 17, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,600
Actual
Start
Dec 2004
Primary completion
Not stated
Study completion May 2006
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Nov 15, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether Symbicort dosed according to the Symbicort Maintenance and Reliever Therapy (SMART) concept is superior to standard asthma treatment according to the local German treatment guidelines.
Conditions
- Asthma
Interventions
Symbicort, used twice daily (b.i.d) and as needed (prn)Drug
Budesonide Turbuhaler 200 µgDrug
Fluticasone Discus 250 µgDrug
Formoterol Turbuhaler 4.5 µgDrug
Terbutaline Turbuhaler 0.5 mgDrug
Salbutamol pressurized metered dose inhaler (pMDI) 100 µgDrug
Salmeterol Discus 50 µgDrug
Budesonide/Formoterol Turbuhaler 160/4.5 µgDrug
Fluticasone/Salmeterol Discus 250/50 µgDrug
Fluticasone/Salmeterol Discus 500/50 µgDrug
Theophylline 200 mgDrug
Theophylline 300 mgDrug
Singulair 10 mgDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first severe asthma exacerbation
Locations
169 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Amberg, Germany
Research Site
Aschaffenburg, Germany
Research Site
Auerbach, Germany
Research Site
Augsburg, Germany
Research Site
Backnang, Germany
Research Site
Bad Arolsen, Germany
Research Site
Bad Doberan, Germany
Research Site
Bad Lippspringe, Germany
Research Site
Bad Neuenahr, Germany
Research Site
Bad Reichenhall, Germany
Research Site
Bad Sessendorf, Germany
Research Site
Bayreuth, Germany
Research Site
Bensheim, Germany
Research Site
Bergisch Gladbach, Germany
Research Site
Berlin, Germany
Research Site
Bitte Eintragen, Germany
Research Site
Bochum, Germany
Research Site
Bonn, Germany
Research Site
Borna, Germany
Research Site
Brake, Germany
Research Site
Burg, Germany
Research Site
Burgwedel, Germany
Research Site
Castrop-Rauxel, Germany
Research Site
Chemnitz, Germany
Research Site
Cologne, Germany
Research Site
Coswig, Germany
Research Site
Cottbus, Germany
Research Site
Damme, Germany
Research Site
Darmstadt, Germany
Research Site
Deggendorf, Germany
Research Site
Dillingen, Germany
Research Site
Dinslaken, Germany
Research Site
Dortmund, Germany
Research Site
Dresden, Germany
Research Site
Dülmen, Germany
Research Site
Düsseldorf, Germany
Research Site
Eisenach, Germany
Research Site
Eisenhüttenstadt, Germany
Research Site
Emden, Germany
Research Site
Erfurt, Germany
Showing 40 of 169 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.